rs116899837 - RN7SKP231 - PRR13P7
Magnitude 2.8 · 1 study on file
Reported associations
-
Identifying the Common Genetic Basis of Antidepressant Response - Unknown journal (n.d.) · Unknown authors · PubMed 35712048
ABSTRACT: Background Antidepressants are a first-line treatment for depression. However, only a third of individuals experience remission after the first treatment. Common genetic variation, in part, likely regulates antidepressant response, yet the success of previous genome-wide association studies has been limited by sample size. This study performs the largest genetic analysis of prospectively assessed antidepressant response in major depressive disorder to gain insight into the underlying biology and enable out-of-sample prediction. Methods Genome-wide analysis of remission (nremit = 1852, nnonremit = 3299) and percentage improvement (n = 5218) was performed. Single nucleotide polymorphism-based heritability was estimated using genome-wide complex trait analysis. Genetic covarian
Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.
Lifestyle context
Concrete actions anchored to the cited research. We do not prescribe, we describe.
Discuss with your doctor
-
antidepressant therapy if depressed Moderate
This variant is associated with improved antidepressant response in major depressive disorder.
If diagnosed with depression, discuss antidepressant medication options with your clinician.